ICUI (STOCKS)
ICU Medical Inc
$143.720000
+1.520000 (+1.07%)
Prev close: $142.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Vivek Jain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,596.33M
- Employees
- 15,000
- P/E (TTM)
- 76.79
- P/B (TTM)
- 1.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.97 | $1.79 | +0.1833 | +10.26% |
|
Dec 2025 (Q4)
|
$1.91 | $1.73 | +0.1843 | +10.68% |
|
Sep 2025 (Q3)
|
$2.03 | $1.46 | +0.5680 | +38.85% |
|
Jun 2025 (Q2)
|
$2.10 | $1.53 | +0.5700 | +37.25% |
Financial Statements
| Revenues | $2.16B |
| Benefits Costs and Expenses | $2.15B |
| Cost Of Revenue | $1.34B |
| Costs And Expenses | $2.15B |
| Gross Profit | $818.16M |
| Nonoperating Income/Loss | $471.00K |
| Operating Expenses | $774.64M |
| Selling, General, and Administrative Expenses | $622.54M |
| Research and Development | $85.48M |
| Other Operating Expenses | $66.61M |
| Operating Income/Loss | $43.52M |
| Income/Loss Before Equity Method Investments | $11.90M |
| Income/Loss From Continuing Operations After Tax | $50.97M |
| Income/Loss From Continuing Operations Before Tax | $11.29M |
| Income/Loss From Equity Method Investments | -$1.80M |
| Income Tax Expense/Benefit | -$36.85M |
| Interest Expense, Operating | $87.80M |
| Net Income/Loss | $46.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $46.34M |
| Net Income/Loss Available To Common Stockholders, Basic | $46.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.87 |
| Diluted Earnings Per Share | $1.86 |
| Basic Average Shares | 74,111,000 |
| Diluted Average Shares | 74,697,000 |
| Assets | $4.01B |
| Current Assets | $1.21B |
| Inventory | $605.59M |
| Other Current Assets | $607.66M |
| Noncurrent Assets | $2.80B |
| Fixed Assets | $445.14M |
| Intangible Assets | $598.97M |
| Other Non-current Assets | $1.76B |
| Liabilities | $1.90B |
| Current Liabilities | $517.90M |
| Accounts Payable | $173.98M |
| Other Current Liabilities | $343.92M |
| Noncurrent Liabilities | $1.38B |
| Equity | $2.11B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.11B |
| Liabilities And Equity | $4.01B |
| Net Cash Flow From Operating Activities | $167.43M |
| Net Cash Flow From Operating Activities, Continuing | $167.43M |
| Net Cash Flow From Investing Activities | $127.83M |
| Net Cash Flow From Investing Activities, Continuing | $127.83M |
| Net Cash Flow From Financing Activities | -$299.31M |
| Net Cash Flow From Financing Activities, Continuing | -$299.31M |
| Exchange Gains/Losses | $2.68M |
| Net Cash Flow | -$1.37M |
| Net Cash Flow, Continuing | -$4.05M |
| Comprehensive Income/Loss | $99.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $99.84M |
| Other Comprehensive Income/Loss | $53.50M |